In this report we evaluated the number and phenotype of blood circulating B
-cell subsets at different stages of differentiation in 26 patients with ne
wly diagnosed multiple myeloma (MM). In all patients, plasma cells and/or p
lasma blasts could be identified by flow cytometry with a mean frequency of
1.20% and 0.07%, respectively. In 76.9% of the patients these cells showed
aberrant expression mainly of CD56, CD28 and CD117, none of these markers
were found on the earlier B-lymphocytes. Clonal B-cells preceding the plasm
a blast stage were identified by patient specific IgH RT-PCR on sorted B-ce
ll subsets. The clonal cells included the less differentiated CD38(+)/CD19(
+) and CD38(-)/CD19(+) subsets, illustrating that the clonal cells are part
of an ongoing differentiation process. Further, the presence of CD38(-)/CD
19(+) cells with somatically mutated C gamma transcripts identical to the t
umor-specific C alpha transcript, shows that the clonal hierarchy in myelom
a may include memory B-cells.